Outpatient low toxic regimen with bortezomib in relapsed/refractory acute lymphoblastic leukemia in pediatrics and AYA patients: Single‐center Mexican experience
Keyword(s):
2018 ◽
Vol 25
(5)
◽
pp. 1182-1186
◽
2019 ◽
Vol 20
(11)
◽
pp. 3391-3398
Keyword(s):